{
  "docId": "019de075-3207-70ec-93a8-5bb5ec3d9629",
  "docSlug": "951aacbbe982699d0f743a597a954ece",
  "documentTitle": "OKYO Pharma | Results Presentation Deck | 25 slides",
  "authorId": "okyo-pharma",
  "authorName": "OKYO Pharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 25,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "other",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide features a molecular structure illustration of the lipid-conjugated peptide.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de075-3207-70ec-93a8-5bb5ec3d9629/9",
  "deckHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629",
  "deckJsonHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629.json",
  "deckAnchorHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.5,
        "y": 0.2
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc2802c5-d67b-4cb0-b4a3-98b4f5a5e33f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.04,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "OKYO has exclusive license for OK-101, a novel membrane-anchored chemerin peptide from OTTx Therapeutics (Boston, MA)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b1171b6-cb2b-4185-8ca5-3d64c3e73df1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.35,
        "x": 0.04,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "First-in-class drug candidate with anti-inflammatory and ocular pain reducing property. Lipid conjugated peptide chemistry minimizes drug washout and enhances the potency. Preservative free, EDTA free. Simple, stable formulation.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95e1dd8e-4c59-4bfb-89b9-4c652f911a2a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "OK-101: A Lipid-Conjugated Chemerin Peptide",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a57c9a42-1762-407d-b41c-6c8ef81ef3f2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}